DK0496135T3 - Cellefri Mareks sygdomsvirus-vaccine - Google Patents

Cellefri Mareks sygdomsvirus-vaccine

Info

Publication number
DK0496135T3
DK0496135T3 DK91203365.1T DK91203365T DK0496135T3 DK 0496135 T3 DK0496135 T3 DK 0496135T3 DK 91203365 T DK91203365 T DK 91203365T DK 0496135 T3 DK0496135 T3 DK 0496135T3
Authority
DK
Denmark
Prior art keywords
disease virus
cell
marek
virus vaccine
vaccine
Prior art date
Application number
DK91203365.1T
Other languages
English (en)
Inventor
William Baxendale
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0496135(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of DK0496135T3 publication Critical patent/DK0496135T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255Marek's disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16361Methods of inactivation or attenuation
    • C12N2710/16364Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK91203365.1T 1990-12-24 1991-12-20 Cellefri Mareks sygdomsvirus-vaccine DK0496135T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90314297 1990-12-24

Publications (1)

Publication Number Publication Date
DK0496135T3 true DK0496135T3 (da) 1994-11-28

Family

ID=8205666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91203365.1T DK0496135T3 (da) 1990-12-24 1991-12-20 Cellefri Mareks sygdomsvirus-vaccine

Country Status (17)

Country Link
US (1) US5378467A (da)
EP (1) EP0496135B1 (da)
JP (1) JP3410744B2 (da)
KR (1) KR100187317B1 (da)
CN (1) CN1034554C (da)
AT (1) ATE109007T1 (da)
CA (1) CA2058386C (da)
DE (1) DE69103130T2 (da)
DK (1) DK0496135T3 (da)
DZ (1) DZ1550A1 (da)
ES (1) ES2061165T3 (da)
HU (2) HUT62200A (da)
IL (1) IL100386A (da)
MX (1) MX9102757A (da)
NZ (1) NZ241122A (da)
SA (1) SA92120430B1 (da)
ZA (1) ZA9110022B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (en) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Marek's disease virus vaccine
US5565202A (en) * 1994-08-12 1996-10-15 The United States Of America As Represented By The Secretary Of Agriculture Low enhancement serotype 2 vaccine for marek's disease
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
ES2436317T3 (es) 2010-05-07 2013-12-30 Deutsches Krebsforschungszentrum Parvovirus de roedor modificado capaz de propagarse y difundirse en gliomas humanos
BR112020012162A2 (pt) 2017-12-20 2020-11-24 Intervet International B.V. diluente aprimorado para vacina contra alfa-herpesvírus associado à célula

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4895718A (en) * 1987-07-10 1990-01-23 The United States Of America, As Represented By The Secretary Of Agriculture Serotype 2 Marek's disease vaccine
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病2価生ワクチンとその製造方法

Also Published As

Publication number Publication date
EP0496135B1 (en) 1994-07-27
HUT62200A (en) 1993-04-28
IL100386A0 (en) 1992-09-06
US5378467A (en) 1995-01-03
MX9102757A (es) 1992-07-01
ATE109007T1 (de) 1994-08-15
JPH04295433A (ja) 1992-10-20
DZ1550A1 (fr) 2002-02-17
HU210344A9 (en) 1995-04-28
EP0496135A3 (en) 1992-08-05
CN1034554C (zh) 1997-04-16
KR100187317B1 (ko) 1999-05-01
ZA9110022B (en) 1992-10-28
NZ241122A (en) 1992-10-28
JP3410744B2 (ja) 2003-05-26
SA92120430B1 (ar) 2004-05-31
CN1064409A (zh) 1992-09-16
CA2058386A1 (en) 1992-06-25
DE69103130T2 (de) 1994-12-01
CA2058386C (en) 2003-02-11
IL100386A (en) 1995-07-31
KR920011520A (ko) 1992-07-24
HU914111D0 (en) 1992-03-30
DE69103130D1 (de) 1994-09-01
ES2061165T3 (es) 1994-12-01
EP0496135A2 (en) 1992-07-29

Similar Documents

Publication Publication Date Title
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
CA2121241A1 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
MY103575A (en) Cannie coronavirus vaccine
DE69103130D1 (de) Zellfreies Marekskrankheitvirus-Vakzin.
IE780360L (en) Vaccine against "egg drop disease".
GR3007856T3 (da)
MX9602256A (es) Vacuna contra la enfermedad de marek.
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
DK1087014T3 (da) Svinepestvirusvaccine og -diagnostik
NZ228232A (en) Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry
DE59209310D1 (de) Impfstoffe auf Basis geänderter Boviner Herpesviren Typ 1
ATE3058T1 (de) Herpes-virus-impfstoff und seine herstellung.
DE3269188D1 (en) Vaccine for hepatitis
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
Baxendale Marek's disease virus vaccine
DE60114908D1 (de) Hühner-Anäemie-Virus mit geringer Pathogenität
Bexendale Cell-free Marek's Disease virus vaccine
Honda et al. Live vaccine for contagious diseases of chickens.
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
Von Ohlinger et al. Boar vaccination against Aujeszky's disease. 2. Communication: Virus excretion in nasal secretions and semen.
Lane Canine vaccination policy.
IL78343A0 (en) Newcastle's disease virus(ndv)vaccine and method for the application thereof